CELG-RI Stock Dividend Yield, History & Forecast

Bristol-Myers Squibb Company Ce (CELG-RI) is a Drug Manufacturers - General company in the Healthcare sector listed on the New York Stock Exchange. It pays a current dividend yield of 3.97% ($2.52 per share annually (TTM)). The most recent ex-dividend date was March 7, 2024, with payment scheduled for March 11, 2024. The trailing twelve-month payout ratio is 55.4%; the market capitalization is approximately $129.66B. Review CELG-RI dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

BF: Lifetime $750 · ends in 13d:11h:16m:00sGet it
Loading quote...

Frequently Asked Questions about Bristol-Myers Squibb Company Ce (CELG-RI)

What is Bristol-Myers Squibb Company Ce's dividend yield?
Bristol-Myers Squibb Company Ce (CELG-RI) pays a current trailing twelve-month dividend yield of 3.97%, which works out to $2.52 per share annually based on the most recent payout schedule.
When does Bristol-Myers Squibb Company Ce pay its next dividend?
The most recent ex-dividend date was March 7, 2024. The next scheduled dividend payment date is March 11, 2024.
Is Bristol-Myers Squibb Company Ce a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Bristol-Myers Squibb Company Ce in?
Bristol-Myers Squibb Company Ce (CELG-RI) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What is Bristol-Myers Squibb Company Ce's dividend payout ratio?
Bristol-Myers Squibb Company Ce (CELG-RI)'s trailing twelve-month dividend payout ratio is 55.4%. The payout ratio measures what percentage of earnings is paid out as dividends — a lower ratio generally suggests a more sustainable dividend.